Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
20.85
-0.18 (-0.86%)
At close: Feb 6, 2026, 4:00 PM EST
21.39
+0.54 (2.59%)
After-hours: Feb 6, 2026, 6:41 PM EST
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.03 billion as of February 6, 2026. Its market cap has increased by 514.78% in one year.
Market Cap
1.03B
Enterprise Value
1.05B
1-Year Change
514.78%
Ranking
Category
Stock Price
$20.85
Market Cap Chart
Since the IPO on November 21, 2016, Nanobiotix's market cap has increased from $249.91M to $1.03B, an increase of 310.34%. That is a compound annual growth rate of 16.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 1.03B | -7.42% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyePoint | 1.08B |
| MoonLake Immunotherapeutics | 1.06B |
| Aktis Oncology | 1.05B |
| Ventyx Biosciences | 1.00B |
| Sana Biotechnology | 994.88M |
| ORIC Pharmaceuticals | 994.34M |
| Phathom Pharmaceuticals | 991.21M |
| Vir Biotechnology | 983.61M |